Strides Pharma ScienceNSE 11.82 % said on Monday it has entered into a joint venture with China’s Sihuan Pharmaceutical Holdings Group with a view to fast track its entry into the neighbouring country. The JV pact...
Pfizer to spinoff, merge off-patent drugs unit with Mylan
Pfizer Inc (PFE.N) has agreed to spin off its off-patent branded drugs business and combine it with generic drugmaker Mylan NV (MYL.O), a move that leaves Pfizer with its more profitable innovative drugs, including...
Pfizer nears deal to combine off-patent drug unit with Mylan
Pfizer Inc. plans to combine its off-patent business, which includes Lipitor cholesterol pills and male-impotence drug Viagra, with Mylan NV and form a generic drug giant, according to people familiar with the matter...
Novartis CEO pledges not to sell Sandoz generics unit
Novartis Chief Executive Vas Narasimhan pledged in an interview published on Saturday not to sell the Swiss drugmaker’s generics unit Sandoz amid a revamp that has prompted speculation he is preparing to offload the...
NCLAT stays sale of Orchid to Dhanuka
The National Company Law Appellate Tribunal (NCLAT) has stayed the sale of Orchid Pharma to Dhanuka Laboratories, in the eleventh hour, as the scheme for the acquisition was to become operational from Saturday. In...
Cipla forms JV with Jiangsu Acebright for respiratory medicines in China
Drugmaker Cipla’s European unit has formed a joint venture with Shanghai-based Jiangsu Acebright to manufacture respiratory products in China, marking the Indian company’s second attempt at entering the Chinese market...
Roche, Spark push back takeover deadline in $4.3 billion deal
Roche and Spark Therapeutics agreed to extend the deadline for the Swiss drugmaker’s $4.3 billion takeover bid for the U.S. gene therapy specialist, Roche said, adding it remains “fully committed” to a deal it sees...
Buyout giants in talks with Wockhardt for domestic formulations business
Buyout funds Apax Partners, Blackstone, Carlyle and KKR are in talks with Wockhardt Ltd, one of India’s oldest drug makers, to acquire a substantial stake in its domestic formulations business, said people aware of the...
GSK-Pfizer joint venture gets conditional approval from South Africa’s competition regulator
GlaxoSmithKline Plc (GSK.L) and Pfizer Inc’s (PFE.N) planned joint venture received conditional approval from a South African regulator on Tuesday, clearing a hurdle in the creation of a consumer health giant with sales...
Strides Pharma arm signs pacts for sale of Australian business to Arrow Pharma
Drug firm Strides Pharma Science Monday said its step-down subsidiary has signed the definitive agreements for sale of its entire Australian business to Arrow Pharmaceuticals upon receipt of all requisite approvals...
Online pharmacy 1mg raises $70 mn in funding round led by Corisol, Redwood
1mg, an integrated healthcare platform, has closed a $70 million fundraise with participation from World Bank investment arm IFC. The financing round was led by Corisol Holdings, a European family office and largest...
AbbVie strikes $63-billion deal for merger with botox-maker Allergan
AbbVie Inc. agreed to pay $63 billion for rival drugmaker Allergan Plc, the latest merger in an industry where some of the biggest companies have been willing to pay a big premium to resolve questions about their growth...
